These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 704535)

  • 1. [Blood levels of vincamine. Comparative study of vincamine in delayed and immediate actions].
    Balcazar de Aztegui MD; Cruz Ramirez J
    Prensa Med Mex; 1978; 43(1-2):61-3. PubMed ID: 704535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relative bioavailability of a vincamine retard formulation. Pharmacokinetic study in normal subjects (author's transl)].
    Erking W; Lücker PW; Metz G; Specker M; Wetzelsberger K
    Arzneimittelforschung; 1978; 28(12):2332-6. PubMed ID: 582951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro dissolution test: evaluation criterion for prolonged release dosage forms vincamine example (author's transl)].
    Buri P; Doelker E; Boucherat J
    Schweiz Rundsch Med Prax; 1981 Jul; 70(29):1310-3. PubMed ID: 7279852
    [No Abstract]   [Full Text] [Related]  

  • 4. Capillary gas chromatographic determination of vincamine in plasma.
    Michotte Y; Massart DL
    J Chromatogr; 1985 Nov; 344():367-71. PubMed ID: 4086560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the in vitro availability of vincamine from delayed-release forms. 1].
    Rolland A; Gibassier D; Chemtob C; Le Verge R
    J Pharm Belg; 1984; 39(2):93-9. PubMed ID: 6470921
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of vincamine.
    Pietta P; Rava A; Catenacci E
    J Chromatogr; 1981 May; 210(1):149-53. PubMed ID: 7251726
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of vincamine in plasma by high-performance liquid chromatography with voltammetric detection.
    Smyth MR
    Analyst; 1986 Jul; 111(7):851-2. PubMed ID: 3752527
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E; Bucalossi A
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic study of vincamine teprosilate.
    Cadórniga R; Saiz Vadillo MC; Molina IT; Cadórniga L
    Int J Clin Pharmacol Res; 1984; 4(4):281-90. PubMed ID: 6500775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma concentrations and renal excretion of vincamine after oral administration in man (author's transl)].
    Siegers CP; Iven H; Strubelt O
    Arzneimittelforschung; 1977; 27(6a):1271-4. PubMed ID: 578451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of multilayer vincamine dragees. Study of normal subjects].
    Lücker PW; Simon B; Talmont DM
    Arzneimittelforschung; 1978; 28(1):79-82. PubMed ID: 580205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vincamine on platelet respiration].
    Pesce E; Viganò V; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):343-50. PubMed ID: 748059
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of vincamine in human plasma using automated high-performance liquid chromatography.
    Dubruc C; Caqueret H; Bianchetti G
    J Chromatogr; 1981 Jan; 204():335-9. PubMed ID: 7217262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronystagmographic study in rabbits on the vestibular effect of vincamine.
    Hamann KF; Bernhold B; Sattler B; Iatraki L
    Arzneimittelforschung; 1979; 29(1):34-8. PubMed ID: 312648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 11-bromovincamine in human plasma by high-performance liquid chromatography.
    Brodie RR; Chasseaud LF
    J Chromatogr; 1982 Mar; 228():413-7. PubMed ID: 7076771
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of spectrum analysis of equilibration recordings (posturography) in clinical pharmacology of vindeburnol].
    Patat A; Foulhoux P; Venet R; Memin Y
    Therapie; 1984; 39(6):639-45. PubMed ID: 6531737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolism of vincamine in the rat].
    Viganò V; Paracchini S; Piacenza G; Pesce E
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic study of oral vincamine].
    Ventouras K; Schulz P; Doelker E; Boucherat J; Bari P
    Pharm Acta Helv; 1976; 51(11):334-42. PubMed ID: 1019177
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of a vincamine-papaverine combination on platelet aggregation in geriatric patients with glucose and/or lipid metabolism disorders].
    Petruzzi E; Bucalossi A; Chiostri R
    Minerva Cardioangiol; 1985 Sep; 33(9):561-4. PubMed ID: 4088484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.